Early Profound Secondary Autoimmune Thrombocytopenia Induced By Clopidogrel In a Coronary Artery Patient

Early Profound Secondary Autoimmune Thrombocytopenia Induced By Clopidogrel In a Coronary Artery Patient

Detalhes bibliográficos
Principais autores:	Volkan Karakuş, Burak Deveci, Erdal Kurtoğlu, Şakir Arslan
Formato:	Artigo
Idioma:	English
Publicado em:	Galenos Publishing House 2012-03-01
coleção:	Turkish Journal of Hematology
Assuntos:	autoimmune thrombocytopenia clopidogrel coronary artery
Acesso em linha:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-59244

Registros relacionados

Thrombocytopenia induced by clopidogrel: a rare adverse effect
por: Catarina Távora, et al.
Publicado em: (2023-10-01)

Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura following Endovascular Treatment of Spontaneous Carotid Artery Dissection
por: Jerry A. Rubano, et al.
Publicado em: (2015-10-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
por: John I. Louca, et al.
Publicado em: (2014-09-01)

Clopidogrel response in acute coronary syndrome : clinical implications & emerging therapies /
por: Miguel Castro, Antonio de
Publicado em: (2011)

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia
por: Francisco José Fernández-Fernández, et al.
Publicado em: (2017-10-01)

Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention
por: Dunya Habeeb Shnain, et al.
Publicado em: (2024-06-01)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
por: Didem Atay, et al.
Publicado em: (2012-03-01)

Recurrent hypoglycemia induced by clopidogrel: A case report and mini review
por: Weiguan Du, et al.
Publicado em: (2024-03-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
por: V. A. Sulimov, et al.
Publicado em: (2015-12-01)

Clopidogrel resistance and genetic factors
por: Alev Arat Özkan
Publicado em: (2013-07-01)

Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients
por: Jean Christophe Stauffer, et al.
Publicado em: (2012-05-01)

The role of clopidogrel in the current treatment of acute coronary syndrome
por: I. S. Yavelov
Publicado em: (2020-06-01)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
por: Dong Wang, et al.
Publicado em: (2018-11-01)

OVERVIEW CHARACTERISTICS AND P2Y12 REACTIVITY UNIT (PRU) VALUES OF ACUTE CORONARY SYNDROME AGE PRODUCTIVE PATIENTS WITH CLOPIDOGREL THERAPY
por: Rahmatini ., et al.
Publicado em: (2018-04-01)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome
por: Wang HD, et al.
Publicado em: (2016-07-01)

Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Di Liu, et al.
Publicado em: (2023-10-01)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Amir Hashemi-meshkini, et al.
Publicado em: (2023-04-01)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Charalambos Vlachopoulos, et al.
Publicado em: (2019-06-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Candice Volney, et al.
Publicado em: (2019-07-01)

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention
por: Chenggang Wang, et al.
Publicado em: (2020-04-01)

Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome
por: Heemanshu Lodhi, et al.
Publicado em: (2024-07-01)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Hyeyeon Moon, et al.
Publicado em: (2021-10-01)

Long-term cost-effectiveness of ticagrelor versus clopidogrel in acute coronary syndrome in Spain
por: E. Molina-Cuadrado, et al.
Publicado em: (2014-07-01)

Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
por: Robert H. Lee, et al.
Publicado em: (2025-01-01)

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz RP, et al.
Publicado em: (2016-06-01)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis
por: Mengyi Sun, et al.
Publicado em: (2022-01-01)

Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores
por: Peng Xiao, et al.
Publicado em: (2021-05-01)

Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis
por: Jing Yang, et al.
Publicado em: (2024-03-01)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
por: Kwan T, et al.
Publicado em: (2011-06-01)

Pharmacodynamic safety of clopidogrel monotherapy in patients under oral anticoagulation with a vitamin K antagonist undergoing coronary stent implantation
por: Christian Valina, et al.
Publicado em: (2019-08-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
por: Fan ZG, et al.
Publicado em: (2019-02-01)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Ziwei Xi, et al.
Publicado em: (2021-11-01)

Current views on antiplatelet therapy in acute coronary syndrome patients: the place of clopidogrel
por: O. O. Shakhmatova
Publicado em: (2022-06-01)

In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
por: Aaron E. Brice, et al.
Publicado em: (2017-04-01)

Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
por: He Meijiao, et al.
Publicado em: (2022-02-01)

Predictors of premature clopidogrel discontinuation within 30 days of successful coronary artery stenting
por: Çayan Cakir, et al.
Publicado em: (2018-01-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
por: Salman Nikfarjam, et al.
Publicado em: (2023-01-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
por: A. L. Alyavi, et al.
Publicado em: (2016-01-01)

Endometrial carcinoma and paraneoplastic immune thrombocytopenia
por: Hilmi Kodaz, et al.
Publicado em: (2016-04-01)

La era de la farmacogenómica: el ejemplo del clopidogrel Farmacogenomics Era: The Clopidogrel Example
por: Allan Ramos-Esquivel, et al.
Publicado em: (2012-03-01)